RELAPSED ADVANCED LYMPHOMAS
Clinical trials for RELAPSED ADVANCED LYMPHOMAS explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ADVANCED LYMPHOMAS trials appear
Sign up with your email to follow new studies for RELAPSED ADVANCED LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to tame advanced lymphoma in early human trial
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called AUR108 in 40 adults whose advanced lymphoma has returned after prior treatment. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. Participants must be in fairly good…
Matched conditions: RELAPSED ADVANCED LYMPHOMAS
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 26, 2026 11:53 UTC
-
New pill for tough lymphoma cancers enters first human tests
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called AUR112 in about 40 adults with relapsed advanced lymphoma (a type of blood cancer that has returned or is hard to treat). The main goals are to check the drug's safety, find the right dose, and see how the body process…
Matched conditions: RELAPSED ADVANCED LYMPHOMAS
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 26, 2026 11:51 UTC